-
Rituximab, sold
under the
brand name
Rituxan among others, is a
monoclonal antibody medication used to
treat certain autoimmune diseases and
types of...
- of t-FL (e.g., the
addition to
standard chemotherapy of
agents such as
rituximab) have
improved overall survival times.
These newer regimens may also delay...
-
antibodies such as
rituximab,
which are
increasingly being used as first-line treatment. In
summer 2018, the FDA
granted full
approval to
rituximab for this application...
- 90% to less than 20%. Immunosuppressants, such as glucocorticoids, and
rituximab may also be used.
Platelet transfusions are
generally not recommended...
-
bendamustine with
rituximab.
Second line
treatment may
include fludarabine,
combined with
cyclophosphamide and/or mitoxantrone,
usually with
rituximab. Cladribine...
- use corticosteroids.[citation needed] The anti-CD20
monoclonal antibody rituximab has been
found to be
effective in
treating some
otherwise refractory cases...
- as
rituximab or
cyclophosphamide and high-dose
corticosteroids to
control the
symptoms of the
disease and azathioprine, methotrexate, or
rituximab to...
-
methotrexate for
moderate to
severe rheumatoid arthritis. The
biologic agent rituximab (anti-B cell therapy) is now
licensed for use in
refractory rheumatoid...
-
combined today with
rituximab. This
regimen is then
called ICE-R or R-ICE or RICE. [R]-ICE
regimen consists of:[citation needed]
Rituximab - an anti-CD20 monoclonal...
- corticosteroids.
Sometimes the
chimeric anti-CD20
monoclonal antibody,
rituximab, is
added to this
treatment regimen to form the R-CHOP regimen. R-miniCHOP...
